English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18076/20274 (89%)
造訪人次 : 5251224      線上人數 : 1197
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34469


    標題: CCDC167 as a potential therapeutic target and regulator of cell cycle-related networks in breast cancer
    作者: Chen, Pin-Shern
    Hsu, Hui-Ping
    Phan, Nam Nhut
    Yen, Meng-Chi
    Chen, Feng-Wei
    Liu, Yu-Wei
    Lin, Fang-Ping
    Feng, Sheng-Yao
    Cheng, Tsung-Lin
    Yeh, Pei-Hsiang
    Omar, Hany A.
    Sun, Zhengda
    Jiang, Jia-Zhen
    Chan, Yi-Shin
    Lai, Ming-Derg
    Wang, Chih-Yang
    Hung, Jui-Hsiang
    貢獻者: Chia Nan Univ Pharm & Sci, Dept Biotechnol
    Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Surg
    Nguyen Tat Thanh Univ, NTT Inst Hitechnol
    Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Emergency Med
    Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med
    Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Dept Biochem & Mol Biol
    Kaohsiung Med Univ, Coll Med, Sch Med, Dept Physiol
    Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Coll Med, Orthoped Res Ctr
    Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Med Res
    Kaohsiung Med Univ, Regenerat Med & Cell Therapy Res Ctr
    Univ Sharjah, Sharjah Inst Med Res
    Univ Sharjah, Coll Pharm
    Ajman Univ, Coll Pharm, Dept Clin Sci
    BeniSuef Univ, Fac Pharm, Dept Pharmacol, Bani Suwayf 62511, Egypt;[Sun, Zhengda
    Kaiser Permanente, Northern Calif Reg Labs, Permanente Med Grp
    Fudan Univ, Huashan Hosp North, Emergency Dept
    Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Canc Biol & Drug Discovery
    Taipei Med Univ, Coll Med Sci & Technol, PhD Program Canc Mol Biol & Drug Discovery
    關鍵字: coiled-coil domain-containing protein 167
    breast cancer
    cell proliferation
    cell growth
    bioinformatics
    日期: 2021
    上傳時間: 2023-11-11 11:55:38 (UTC+8)
    出版者: IMPACT JOURNALS LLC
    摘要: According to cancer statistics reported in 2020, breast cancer constitutes 30% of new cancer cases diagnosed in American women. Histological markers of breast cancer are expressions of the estrogen receptor (ER), the progesterone receptor (PR), and human epidermal growth factor receptor (HER)-2. Up to 80% of breast cancers are grouped as ER-positive, which implies a crucial role for estrogen in breast cancer development. Therefore, identifying potential therapeutic targets and investigating their downstream pathways and networks are extremely important for drug development in these patients. Through high-throughput technology and bioinformatics screening, we revealed that coiled-coil domain-containing protein 167 (CCDC167) was upregulated in different types of tumors; however, the role of CCDC167 in the development of breast cancer still remains unclear. Integrating many kinds of databases including ONCOMINE, MetaCore, IPA, and KaplanMeier Plotter, we found that high expression levels of CCDC167 predicted poor prognoses of breast cancer patients. Knockdown of CCDC167 attenuated aggressive breast cancer growth and proliferation. We also demonstrated that treatment with fluorouracil, carboplatin, paclitaxel, and doxorubicin resulted in decreased expression of CCDC167 and suppressed growth of MCF-7 cells. Collectively, these findings suggest that CCDC167 has high potential as a therapeutic target for breast cancer.
    關聯: AGING-US, v.13, n.3, pp.4157-4181
    顯示於類別:[生物科技系(所)] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    aging.202382.pdf4414KbAdobe PDF166檢視/開啟
    index.html0KbHTML302檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋